This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 955756.

Paul Vrenken (ESR10) – Science Slam in the Spotlight

Introducing Paul Vrenken (ESR10). In this video, Paul introduces his individual project on in silico methods for selecting oral formulations and dosing conditions in early clinical studies.

Each InPharma ESR developed their own science slam to introduce their project as part of InPharma’s outreach and open access strategy. Watch all 13 science slams on our YouTube channel.